XML 27 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Millions
Total
Common stock
Common stock in treasury
Additional contributed capital
Retained earnings
Accumulated other comprehensive income (loss)
Total Baxter stockholders' equity
Noncontrolling interests
Beginning of year (in shares) at Dec. 31, 2020   683,000,000            
Beginning of year at Dec. 31, 2020 $ 8,726 $ 683 $ (11,051) $ 6,043 $ 16,328 $ (3,314) $ 8,689 $ 37
Beginning of year (in shares) at Dec. 31, 2020     179,000,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 1,295       1,284   1,284 11
Other comprehensive income (loss) $ (66)         (66) (66)  
Purchases of common stock (in shares) 7,300,000   7,000,000          
Purchases of treasury stock $ (600)   $ (600)       (600)  
Stock issued under employee benefit plans and other (in shares)     (4,000,000)          
Stock issued under employee benefit plans and other 317   $ 163 154     317  
Dividends declared on common stock (547)       (547)   (547)  
Change in noncontrolling interests (4)             (4)
End of year (in shares) at Dec. 31, 2021   683,000,000            
End of year at Dec. 31, 2021 9,121 $ 683 $ (11,488) 6,197 17,065 (3,380) 9,077 44
End of year (in shares) at Dec. 31, 2021     182,000,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (2,421)       (2,433)   (2,433) 12
Other comprehensive income (loss) $ (458)         (453) (453) (5)
Purchases of common stock (in shares) 500,000   0          
Purchases of treasury stock $ (32)   $ (32)       (32)  
Stock issued under employee benefit plans and other (in shares)     (3,000,000)          
Stock issued under employee benefit plans and other 256   $ 131 125     256  
Dividends declared on common stock (582)       (582)   (582)  
Change in noncontrolling interests 11             11
End of year (in shares) at Dec. 31, 2022   683,000,000            
End of year at Dec. 31, 2022 $ 5,895 $ 683 $ (11,389) 6,322 14,050 (3,833) 5,833 62
End of year (in shares) at Dec. 31, 2022 179,062,594   179,000,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) $ 2,663       2,656   2,656 7
Other comprehensive income (loss) 276         279 279 (3)
Stock issued under employee benefit plans and other (in shares)     (3,000,000)          
Stock issued under employee benefit plans and other 226   $ 159 67     226  
Dividends declared on common stock (592)       (592)   (592)  
End of year (in shares) at Dec. 31, 2023   683,000,000            
End of year at Dec. 31, 2023 $ 8,468 $ 683 $ (11,230) $ 6,389 $ 16,114 $ (3,554) $ 8,402 $ 66
End of year (in shares) at Dec. 31, 2023 175,861,893   176,000,000